AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Voglicose GM 2mg/500mg/0.3mg Tablet

Prescription Icon
Prescription Required

Marketer

Aster Medipharm Pvt Ltd

Salt Composition

Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.3mg)

Overview Voglicose GM 2mg/500mg/0.3mg Tablet

Diabetic medication, Glyconorm 2mg/500mg/0.3mg tablets, combines multiple agents to manage type 2 diabetes in adults. This formulation helps regulate blood glucose. Administer Glyconorm with food, consistently at the same time daily for optimal effect. Dosage is determined by your physician and may be adjusted based on your blood sugar readings. Continuous use is crucial; discontinuation without medical supervision can lead to elevated blood sugar, potentially causing kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication complements a comprehensive diabetes management plan, including a balanced diet, regular exercise, and weight management as directed by your doctor. Lifestyle modifications are essential for diabetes control. Hypoglycemia (low blood sugar) is a common side effect; learn to identify symptoms like sweating, dizziness, headache, and tremors, and know how to treat it promptly. Maintain regular mealtimes and carry a fast-acting glucose source. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Other potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, edema, blurred vision, fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver impairment. Inform your doctor of any history of heart disease before starting treatment; Glyconorm may not be appropriate for all patients. Pregnant or lactating individuals should seek medical advice before use. Regular blood sugar monitoring, along with blood tests to assess blood cell counts and liver function, are recommended.

Primary Ingredients of Voglicose GM 2mg/500mg/0.3mg Tablet

No text provided to rephrase.

Uses of Voglicose GM 2mg/500mg/0.3mg Tablet

Managing type 2 diabetes

Major Benefits of Voglicose GM 2mg/500mg/0.3mg Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Voglicose GM 2mg/500mg/0.3mg Tablets should be administered on an empty stomach.

Common Side effects of Voglicose GM 2mg/500mg/0.3mg Tablet:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Voglicose GM 2mg/500mg/0.3mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Voglicose GM 2mg/500mg/0.3mg Tablet whole; avoid chewing, crushing, or breaking it. Administer on an empty stomach.

How Voglicose GM 2mg/500mg/0.3mg Tablet works:

Each Voglicose GM tablet (2mg/500mg/0.3mg) contains a triple combination of antidiabetic agents.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of alcohol and Voglicose GM 2mg/500mg/0.3mg tablets is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Voglicose GM 2mg/500mg/0.3mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any risks before prescribing this medication. Seek medical advice before use.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Voglicose GM 2mg/500mg/0.3mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyUNSAFE

The use of Voglicose GM 2mg/500mg/0.3mg tablets is likely unsafe for individuals with kidney impairment and should be omitted. Medical advice is recommended. Furthermore, its administration is discouraged in patients exhibiting severe kidney dysfunction.

LiverLiverCAUTION

Patients with liver impairment should use Voglicose GM 2mg/500mg/0.3mg tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. In those with mild to moderate liver disease, initiation should be at a low dose; however, use is contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Voglicose GM 2mg/500mg/0.3mg Tablet :

Should you forget to take a Voglicose GM 2mg/500mg/0.3mg Tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Voglicose GM 2mg/500mg/0.3mg Tablet

LabelValue
Potential for Dependence None.
Medication Classification Medication for diabetes

FAQs on Voglicose GM 2mg/500mg/0.3mg Tablet

The tablet Voglicose GM (2mg/500mg/0.3mg) combines glimepiride, metformin, and voglibose to manage type 2 diabetes mellitus in adults. This medication, used alongside diet and exercise, helps regulate blood sugar. Glimepiride stimulates insulin secretion from the pancreas, while metformin reduces hepatic glucose production and enhances insulin responsiveness. Voglibose, an alpha-glucosidase inhibitor, decreases post-meal blood glucose. This formulation is unsuitable for type 1 diabetes.
Taking Voglicose GM 2mg/500mg/0.3mg tablets may result in common adverse reactions such as low blood sugar, queasiness, loose stools, taste disturbances, gas, abdominal discomfort, cephalalgia, dermatitis, and upper respiratory infection.
Patients with hypersensitivity to Voglicose GM 2mg/500mg/0.3mg Tablet constituents or inactive ingredients should not receive this medication. Its administration is contraindicated in individuals with moderate to severe renal impairment, inflammatory bowel disorders, colonic ulcers, and pre-existing metabolic acidosis, encompassing diabetic ketoacidosis.
Combining Voglicose GM 2mg/500mg/0.3mg tablets and alcohol is unsafe. This combination may cause dangerously low blood sugar and heighten the risk of lactic acidosis.
Indeed, Voglicose GM 2mg/500mg/0.3mg Tablets may induce hypoglycemia. Low blood sugar can manifest as nausea, headache, irritability, hunger pangs, sweating, lightheadedness, tachycardia, and feelings of unease or tremor. This risk increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Consequently, consistent blood glucose monitoring is crucial. Carrying glucose tablets, honey, or fruit juice is advisable.
Retain this medication within its original, sealed packaging. Follow the storage guidelines printed on the package or label. Discard any leftover medication. Ensure it remains inaccessible to children, pets, and others.
Voglicose GM 2mg/500mg/0....
108
MRP 132
18% off